Malaria
📧 Sign up to get email alerts when something new happens for Malaria.
Sign up freeTop drugs studied for this disease
-
CLINICAL_TRIALS trial_result · 2023-09-22Clinical Trial Update: Therapeutic Efficacy of Chloroquine Plus Primaquine in the Treatment of Uncomplicated Plasmodium Vivax [Phase 4]
Phase 4 trial assessing the therapeutic efficacy of chloroquine plus primaquine in uncomplicated Plasmodium vivax malaria has completed.
-
FDA approval · 2023-09-14FDA Approved: SOVUNA — Supplemental Application (ANI Pharmaceuticals, Inc.)
The FDA approved a supplemental application for SOVUNA (hydroxychloroquine sulfate) submitted by ANI Pharmaceuticals, under NDA 214581.
-
CLINICAL_TRIALS trial_result · 2023-09-13Clinical Trial Update: Dihydroartemisinin-Piperaquine or Sulphadoxine-Pyrimethamine for the Chemoprevention of Malaria in Sickle Cell Anaemia [Phase 3]
Phase 3 trial evaluating dihydroartemisinin-piperaquine or sulfadoxine-pyrimethamine for malaria chemoprevention in children with sickle cel…
-
CLINICAL_TRIALS research · 2023-09-13Clinical Trial Update: Combination Momordica Charantia Extract and Primaquine Againts Plasmodium Falciparum Uncomplicated and Plasmodium Vivax Uncomplicated Treatment in Manokwari, West Papua [Phase 2]
A Phase 2 clinical trial evaluated a combination of Momordica Charantia extract with primaquine for the treatment of uncomplicated Plasmodiu…
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Comparing Chemoprevention Drugs for School-based Malaria Control [Phase 4]
A Phase 4 clinical trial comparing chemoprevention drugs for school-based malaria control has completed.
- Want full summaries, importance scores, and drug timelines? Upgrade to Plus or Pro.
-
CLINICAL_TRIALS trial_result · 2023-08-07Clinical Trial Update: Chemoprevention Efficacy Study Nigeria [Phase 4]
Phase 4 clinical trial update focusing on malaria chemoprevention efficacy; current status is unknown.
-
CLINICAL_TRIALS trial_result · 2023-08-03Clinical Trial Update: A Study to Determine if a New Malaria Vaccine is Safe and Induces Immunity Among Kenyan Adults, Young Children and Infants [Phase 1, Phase 2]
A multicenter early-phase trial evaluating safety and immunogenicity of a new malaria vaccine in Kenyan adults, children, and infants has co…
-
FDA approval · 2023-07-24FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Rising Pharma Holdings, Inc.)
The FDA approved a supplemental application for CHLOROQUINE PHOSPHATE filed by Rising Pharma Holdings, Inc. under ANDA 091621.
-
FDA approval · 2023-07-24FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Amneal Pharmaceuticals of New York LLC)
FDA approved a supplemental application for chloroquine phosphate from Amneal Pharmaceuticals of New York LLC, approving the generic product…
-
FDA approval · 2023-07-24FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Suven Pharmaceuticals Limited)
FDA approved Suven Pharmaceuticals Limited's supplemental application for chloroquine phosphate under ANDA214756. This approval enables the …
-
CLINICAL_TRIALS trial_result · 2023-07-24Clinical Trial Update: A Crossover Bioavailability Clinical Trial of Parenteral Pyronaridine and Artesunate [Phase 1, Phase 2]
A crossover bioavailability study of parenteral pyronaridine and artesunate is being conducted in Phase 1 and Phase 2 for severe malaria tre…
-
CLINICAL_TRIALS trial_result · 2023-07-18Clinical Trial Update: Safety and Efficacy of Maytenus Senegalensis for the Treatment of Uncomplicated Malaria [Phase 2]
Phase 2 trial update evaluating safety and efficacy of Maytenus senegalensis for uncomplicated malaria has completed.
-
CLINICAL_TRIALS trial_result · 2023-07-11Clinical Trial Update: Blood-Stage Plasmodium Vivax Cell Bank [Phase 1]
Phase 1 clinical trial update for a Blood-Stage Plasmodium vivax cell bank; trial completed with results posted in 2023.
-
CLINICAL_TRIALS trial_result · 2023-06-26Clinical Trial Update: Gut and Azithromycin Mechanisms in Infants and Children II [Phase 4]
A Phase 4 clinical trial update on mechanisms of gut and azithromycin in infants and children for malaria, with completed status and posted …
-
CLINICAL_TRIALS trial_result · 2023-06-13Clinical Trial Update: Effect of Paracetamol on Kidney Function in Severe Malaria [Phase 3]
Phase 3 trial investigating the effect of paracetamol on kidney function in patients with severe malaria.
-
CLINICAL_TRIALS trial_result · 2023-06-12Clinical Trial Update: DHA-PQP vs Chloroquine and Primaquine for Radical Cure of Vivax Malaria in Brazil [Phase 3]
Phase 3 trial comparing DHA-PQP versus chloroquine plus primaquine for radical cure of vivax malaria in Brazil has completed.
-
FDA approval · 2023-06-12FDA Approved: PRIMAQUINE PHOSPHATE — Supplemental Application (Ingenus Pharmaceuticals, LLC)
The FDA approved a supplemental application for Primaquine Phosphate from Ingenus Pharmaceuticals, LLC under an ANDA, enabling the generic p…
-
CLINICAL_TRIALS withdrawal · 2023-05-11Clinical Trial Update: Primaquine Double Dose for Radical Cure of Plasmodium Vivax in Colombia [Phase 2, Phase 3]
A phase 2/3 trial evaluating a double-dose primaquine regimen for radical cure of Plasmodium vivax in Colombia has been withdrawn.
-
FDA approval · 2023-05-05FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Sun Pharmaceutical Industries, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate from Sun Pharmaceutical Industries, Inc., updating the approval for t…
-
CLINICAL_TRIALS trial_result · 2023-04-26Clinical Trial Update: MSP3-CRM-Vac4All/ Alhydrogel® Vaccine [Phase 1, Phase 2]
Phase 1/2 clinical trial update for the MSP3-CRM-Vac4All/Alhydrogel vaccine addressing malaria caused by Plasmodium falciparum.
-
CLINICAL_TRIALS trial_result · 2023-04-18Clinical Trial Update: Trial to Evaluate CIS43LS in Healthy Adults [Phase 1]
Phase 1 trial evaluating CIS43LS in healthy adults for malaria has completed; results posted in 2023.
-
FDA approval · 2023-03-30FDA Approved: HYDROXYCHLOROQUINE SULFATE — Supplemental Application (Teva Pharmaceuticals USA, Inc.)
FDA approved a supplemental application for hydroxychloroquine sulfate filed by Teva Pharmaceuticals USA, Inc., marking an approved change u…
-
CLINICAL_TRIALS trial_result · 2023-03-27Clinical Trial Update: Safety, Tolerability, and Pharmacokinetics and Pharmacodynamics of TB31F [Phase 1]
Phase 1 trial update reporting safety, tolerability, pharmacokinetics, and pharmacodynamics of TB31F for malaria caused by Plasmodium falcip…
-
FDA approval · 2023-03-10FDA Approved: CHLOROQUINE PHOSPHATE — Supplemental Application (Suven Pharmaceuticals Limited)
FDA approved a supplemental application for chloroquine phosphate from Suven Pharmaceuticals Limited, enabling the availability of a generic…
-
CLINICAL_TRIALS trial_result · 2023-03-07Clinical Trial Update: Seasonal Malaria Chemoprevention With Dihydroartemisin Piperaquin vs. Sulfadoxine-pyrimethamin+Amodiaquin [Phase 3]
Phase 3 trial update comparing dihydroartemisinin-piperaquine versus sulfadoxine-pyrimethamine+amodiaquine for seasonal malaria chemoprevent…